Juda Scott 4
4 · Inmune Bio, Inc. · Filed Dec 9, 2024
Insider Transaction Report
Form 4
Inmune Bio, Inc.INMB
Juda Scott
Director
Transactions
- Award
Option (right to buy)
2024-12-05+32,500→ 32,500 totalExercise: $5.05Exp: 2034-12-04→ Common Stock (32,500 underlying)
Footnotes (1)
- [F1]Granted pursuant to the 2021 Stock Incentive Plan. The option will become 100% vested and exercisable on December 5, 2026, the two-year anniversary of the grant date.